Recent developments and future directions in Guillain-Barré syndrome.
about
Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in GermanyThe incidence and triggers of adult-onset Guillain-Barré syndrome in southwestern Finland 2004-2013.[Guillain-Barré syndrome after exposure to influenza].Post-Traumatic brain injury (TBI) presenting with Guillain-Barré syndrome and elevated anti-ganglioside antibodies: a case report and review of the literature.Schwann Cells: Development and Role in Nerve RepairC1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy.Biological drugs in Guillain-Barré Syndrome: an update.Tumor necrosis factor-α in Guillain-Barré syndrome, friend or foe?Successful treatment of refractory Guillain-Barré syndrome with alemtuzumab in a patient with chronic lymphocytic leukemia.
P2860
Q30362413-3BC73A5E-AD0E-4ED4-A425-1CCDDC5416AEQ30366527-15149E73-49E1-4504-8C57-801B602A3011Q30415924-2776A356-3987-4D8D-B8E8-FA254A115886Q38243374-9CDECDB9-DA36-485B-8A1A-7F5C96EAD86BQ38468684-BD343F2B-FA46-44F0-870A-8B5578D8B15FQ38748904-ACA3B5A4-96BC-4FC5-B9A7-D0988F59AF3FQ38783298-30715ABE-4EEF-4BE2-B996-5F9937496814Q39000208-E18C9A94-0BB5-4F1E-B9FB-CD7B83350867Q42217116-3765EE6D-C659-4F94-A29C-43FB69B8C8B1
P2860
Recent developments and future directions in Guillain-Barré syndrome.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Recent developments and future directions in Guillain-Barré syndrome.
@en
type
label
Recent developments and future directions in Guillain-Barré syndrome.
@en
prefLabel
Recent developments and future directions in Guillain-Barré syndrome.
@en
P2860
P1476
Recent developments and future directions in Guillain-Barré syndrome.
@en
P2093
Helmar C Lehmann
Richard A C Hughes
P2860
P356
10.1111/J.1529-8027.2012.00433.X
P478
17 Suppl 3
P577
2012-12-01T00:00:00Z